While current research, including case studies and clinical trials, describes potential for experiencing severe adverse psychiatric symptoms such as anxiety, depression, suicidal ideation, and personality changes after initiating GLP-1 receptor agonist treatment, some research suggests that the use of these drugs did not increase psychiatric problems
In cases where a deviation from this standard is used, an explanation is offered as to the reasons, the assumptions, and the revised approach
The Formulation of Saxenda Its worth noting that Saxenda uses the GLP-1 receptor agonist liraglutide
Thats why platforms like Hers offers a new model that makes GLP-1 injections and oral medication accessible, affordable, and straightforward
Immune Support : Maintaining adequate levels is vital for a robust immune response against infections
We understand that cost can be a barrier to accessing weight loss medications